texas oncology more breakthroughs. more victories
We’re experiencing severe weather in the state of Texas. Some of our cancer centers are delayed opening or are closed. View More Important Notifications x

Estil Vance, M.D.


Dr. Vance received his M.D. from Johns Hopkins University School of Medicine in Baltimore, Maryland, where he completed his internship and residency. He completed fellowships at Harvard Medical School, Dana-Farber Cancer Institute in Boston, Massachusetts, Brigham and Women’s Hospital, and Harvard-MIT Health Sciences and Technology.

Accolades & Memberships

Dr. Vance was formerly a medicine instructor at Harvard School of Medicine and Dana-Farber Cancer Institute and an associate physician at Brigham & Women’s Hospital.


  • Maribavir Prophylaxis for Prevention of Cytomegalovirus Infection in Allogeneic Stem-Cell Transplant Recipients: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study

    Blood, 2007

Research Interest

In addition to his interest and experience in blood and marrow transplantation, Estil A. Vance III, M.D., is an expert in the field of oncology-related infections.

Related Stories